Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01758328
What this trial is testing

Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 29
Not applicableStudy completedNCT03654404
What this trial is testing

A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 29
Not applicableStudy completedNCT01611298
What this trial is testing

Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaChronic Myelogenous Leukemia+3 more
Robert Krance 7
Large-scale testing (Phase 3)Study completedNCT00822393
What this trial is testing

Clinical Phase III Trial Treosulfan-based Conditioning Versus Reduced-intensity Conditioning (RIC)

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
medac GmbH 570
Not applicableLooking for participantsNCT06076226
What this trial is testing

A Retrospective Study on the Relationship Between Donor Leukocyte Telomere Length and Prognosis of Acute Leukemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute Leukemia
Zhejiang University 2,500
Testing effectiveness (Phase 2)Study completedNCT00867529
What this trial is testing

Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more
Fred Hutchinson Cancer Center 63
Not applicableLooking for participantsNCT06946654
What this trial is testing

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Who this might be right for
ElderlyGeriatric AssessmentALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Peking University People's Hospital 176
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Ended earlyNCT01500161
What this trial is testing

Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more
Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Looking for participantsNCT06815003
What this trial is testing

Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Myelomonocytic Leukemia+3 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07493408
What this trial is testing

Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML

Who this might be right for
Ph+ Acute Lymphoblastic Leukemia (Ph+ALL)Blastic Transformation of Chronic Myeloid LeukemiaPhiladelphia Chromosome-positive B-cell Acute Lymphoblastic Leukemia (Ph+ B-ALL)+1 more
The University of Hong Kong
Testing effectiveness (Phase 2)Study completedNCT02683525
What this trial is testing

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Graft vs Host DiseaseHematopoietic Stem Cell Transplantation
Sherif S. Farag 37
Not applicableStudy completedNCT00088543
What this trial is testing

Thymoglobulin to Prevent Acute Graft vs. Host Disease (GvHD) in Patients With Acute Lymphocytic Leukemia (ALL) or Acute Myelogenous Leukemia (AML) Receiving a Stem Cell Transplant

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Graft vs. Host Disease (GvHD)
Genzyme, a Sanofi Company 60
Not applicableStudy completedNCT03324620
What this trial is testing

Effectiveness Rehabilitation Hematopoietic Transplantation (ovERsHOT)

Who this might be right for
Hematopoietic Stem Cell Transplantation
Hospital Clinic of Barcelona 190
Testing effectiveness (Phase 2)Ended earlyNCT01045382
What this trial is testing

MSC and HSC Coinfusion in Mismatched Minitransplants

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphoblastic, AcuteLeukemia, Myelocytic, Chronic+6 more
University of Liege 39
Testing effectiveness (Phase 2)WithdrawnNCT03986086
What this trial is testing

MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Malignancy
Nelson Chao
Not applicableActive Not RecruitingNCT04217356
What this trial is testing

Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk Myelofibrosis

Who this might be right for
MyelofibrosisHigh-Risk CancerBone Marrow Cancer
University Health Network, Toronto 90
Testing effectiveness (Phase 2)Ended earlyNCT01135329
What this trial is testing

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Who this might be right for
LymphomaLeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Early research (Phase 1)Study completedNCT01700751
What this trial is testing

Brentuximab Vedotin Prevention of (GVHD) After Unrelated Allogeneic Stem Cell Transplantation

Who this might be right for
Leukemia, Acute MyeloidLeukemia, Lymphoblastic,AcuteMyelodysplastic Syndromes
Washington University School of Medicine 17
Testing effectiveness (Phase 2)Ended earlyNCT05502783
What this trial is testing

Using Fostamatinib to Treat Post-Hematopoietic Stem Cell Transplant Immune-mediated Cytopenias

Who this might be right for
Immune Mediated AnemiaImmune Mediated ThrombocytopeniaChronic GVHD
National Heart, Lung, and Blood Institute (NHLBI) 1
Next Page
45